Treatment of inflammatory diseases with mammal beta defensins

Details for Australian Patent Application No. 2009272680 (hide)

Owner Novozymes Adenium Biotech A/S

Inventors Andersen, Birgitte; Kruse, Thomas; Mygind, Per Holse; Kjaerulff, Soeren; Brinch, Karoline Sidelmann; Kjaer, Tanja Maria Rosenkilde

Agent Shelston IP

Pub. Number AU-A-2009272680

PCT Pub. Number WO2010/007165

Priority 08163614.4 03.09.08 EP; 08162486.8 15.08.08 EP; 08160761.6 18.07.08 EP; 09160448.8 15.05.09 EP

Filing date 17 July 2009

Wipo publication date 21 January 2010

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

10 February 2011 PCT application entered the National Phase

  PCT publication WO2010/007165 Priority application(s): WO2010/007165

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009272681-Treatment of inflammatory bowel diseases with mammal beta defensins

2009272672-Inorganic particles comprising an organic coating that can be hydrophilically/hydrophobically temperature controlled